FOLD – amicus therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Amicus Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Amicus Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Amicus Therapeutics, Inc. (NASDAQ: FOLD) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
Why Are Amicus, Immunocore, & Immuneering Stocks Trading Lower On Friday? [Yahoo! Finance]
Amicus Therapeutics, Inc. (NASDAQ: FOLD) had its "equal weight" rating re-affirmed by analysts at Morgan Stanley. They now have a $12.00 price target on the stock, down previously from $17.00.
Form 4 AMICUS THERAPEUTICS, For: Dec 02 Filed by: Campbell Bradley L
Form 144 AMICUS THERAPEUTICS, Filed by: Campbell Bradley L
Form SC 13G/A AMICUS THERAPEUTICS, Filed by: Redmile Group, LLC
Form SC 13G AMICUS THERAPEUTICS, Filed by: WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC
Form SC 13G/A AMICUS THERAPEUTICS, Filed by: Avoro Capital Advisors LLC
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.